Abstract
Lipooligosaccharides are the most abundant cell surface glycoconjugates on the outer membrane of Gram-negative bacteria. They play important roles in host-microbe interactions. Certain Gram-negative pathogenic bacteria cap their lipooligosaccharides with the sialic acid, N-acetylneuraminic acid (Neu5Ac), to mimic host glycans that among others protects these bacteria from recognition by the hosts immune system. This process of molecular mimicry is not fully understood and remains under investigated. To explore the functional role of sialic acid-capped lipooligosaccharides at the molecular level, it is important to have tools readily available for the detection and manipulation of both Neu5Ac on glycoconjugates and the involved sialyltransferases, preferably in live bacteria. We and others have shown that the native sialyltransferases of some Gram-negative bacteria can incorporate extracellular unnatural sialic acid nucleotides onto their lipooligosaccharides. We here report on the expanded use of native bacterial sialyltransferases to incorporate neuraminic acids analogs with a reporter group into the lipooligosaccharides of a variety of Gram-negative bacteria. We show that this approach offers a quick strategy to screen bacteria for the expression of functional sialyltransferases and the ability to use exogenous CMP-Neu5Ac to decorate their glycoconjugates. For selected bacteria we also show this strategy complements two other glycoengineering techniques, Metabolic Oligosaccharide Engineering and Selective Exo-Enzymatic Labeling, and that together they provide tools to modify, label, detect and visualize sialylation of bacterial lipooligosaccharides.
Original language | English |
---|---|
Number of pages | 13 |
Journal | Glycobiology |
Volume | 34 |
Issue number | 10 |
DOIs | |
Publication status | Published - 30 Aug 2024 |
Bibliographical note
Publisher Copyright:© The Author(s) 2024. Published by Oxford University Press.
Funding
We thank Prof. dr. Geert-Jan Boons and dr. Gerlof P. Bosman for providing the recombinant sialyltransferases used in the SEEL experiments. Prof. dr. Nina van Sorge and the Netherlands Reference Laboratory for Bacterial Meningitis (NRLBM) for generously providing the N. meningitidis strains L1-L12. Dr. Karin Strijbis and Celia Segui-Perez for providing the Prevotella strains described in this study. Nontypeable H. influenzae R2886 and the siaP mutant were a kind gift from dr. Jeroen Langereis, Radboudumc. Other nontypeable H. influenzae and typeable strains were a kind gift from Clinical Infectiology, Utrecht University. Normal Human Serum (NHS) was a kind gift from prof. dr. Suzan Rooijakkers from UMC Utrecht. Dr. Astrid Heikema from Erasmus MC Rotterdam for providing C. jejuni GB strains and their cstII mutants. Prof. dr. Jos van Putten for the N. gonorrhoeae and N. meningitidis serogroup B, C, W-135 and Y strains. Dr. Maria J. Moure for the Sia-AF488-CMP used in this study.
Funders | Funder number |
---|---|
European Union's Horizon 2020 Marie Sklstrok;odowska-Curie Actions for the Innovative Training Network "Sweet Crosstalk" | L1-L12 |
Radboudumc | W-135 |
Keywords
- glycoengineering
- Gram-negative bacteria
- lipooligosaccharides
- sialic acid
- sialyltransferases